Sanna-kaisa K. Herukka

P.O. Box 100, 70029 KYS
Kuopio, 70029, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.

Journal: Journal of Alzheimer's disease : JAD

Published: March 23, 2026

Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.

Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: January 23, 2026

Genetic architecture of Alzheimer's disease-related plasma biomarkers.

Genetic architecture of Alzheimer's disease-related plasma biomarkers.

Journal: Neurobiology of aging

Published: January 20, 2026

Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial.

Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial.

Journal: JAMA network open

Published: December 08, 2025

Combining a computerized cognitive test with serum biomarkers improves detection of early-onset neurodegenerative disorders.

Combining a computerized cognitive test with serum biomarkers improves detection of early-onset neurodegenerative disorders.

Journal: Journal of Alzheimer's disease : JAD

Published: October 27, 2025

Scalable biological-cognitive profiling for Alzheimer's disease in the population.

Scalable biological-cognitive profiling for Alzheimer's disease in the population.

Journal: Brain communications

Published: August 04, 2025

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

Journal: BMJ neurology open

Published: July 30, 2025

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 02, 2025

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

Journal: Nature communications

Published: June 23, 2025

GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagy.

GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagy.

Journal: Research square

Published: June 05, 2025

Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.

Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.

Journal: Journal of Alzheimer's disease : JAD

Published: March 28, 2025

Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism.

Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism.

Journal: Acta neuropathologica communications

Published: February 21, 2025

Showing 1-12 of 128

Last Updated: 09/26/2026